Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,314 | 44 | 50.2% |
| Consulting Fee | $2,800 | 2 | 42.4% |
| Unspecified | $352.00 | 1 | 5.3% |
| Travel and Lodging | $139.52 | 2 | 2.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UroGen Pharma, Inc. | $3,228 | 4 | $0 (2022) |
| Boston Scientific Corporation | $707.53 | 11 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $355.78 | 4 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $262.60 | 2 | $0 (2023) |
| Photocure Inc | $253.79 | 2 | $0 (2023) |
| AbbVie, Inc. | $231.13 | 3 | $0 (2018) |
| Philips Electronics North America Corporation | $214.37 | 3 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $183.81 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $183.18 | 2 | $0 (2018) |
| EDAP TECHNOMED INC | $141.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.33 | 3 | Baxter Healthcare ($139.52) |
| 2023 | $548.33 | 5 | Myriad Genetic Laboratories, Inc. ($262.60) |
| 2022 | $2,911 | 4 | UroGen Pharma, Inc. ($2,800) |
| 2021 | $176.14 | 3 | UROGEN PHARMA, INC. ($75.56) |
| 2020 | $352.00 | 1 | UROGEN PHARMA, INC. ($352.00) |
| 2019 | $536.53 | 8 | Dendreon Pharmaceuticals LLC ($226.29) |
| 2018 | $1,118 | 16 | Boston Scientific Corporation ($362.36) |
| 2017 | $713.75 | 9 | EDAP TECHNOMED INC ($141.71) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $109.81 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Baxter Healthcare | PERCLOT (Device) | Travel and Lodging | In-kind items and services | $96.27 | General |
| Category: Surgical Care | ||||||
| 06/01/2024 | Baxter Healthcare | PERCLOT (Device) | Travel and Lodging | In-kind items and services | $43.25 | General |
| Category: Surgical Care | ||||||
| 12/06/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $136.75 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2023 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $19.56 | General |
| 04/28/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $231.35 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $129.42 | General |
| Category: Urology Gynecology | ||||||
| 04/25/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2022 | UroGen Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 05/13/2022 | Boston Scientific Corporation | General - Therapies (Device) | Food and Beverage | In-kind items and services | $93.86 | General |
| Category: General - Therapies_URO | ||||||
| 04/09/2022 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $17.23 | General |
| 02/28/2022 | UroGen Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/08/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $74.00 | General |
| Category: Oncology | ||||||
| 08/19/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $75.56 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/04/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: SURGERY | ||||||
| 12/31/2020 | UROGEN PHARMA, INC. | JELMYTO (Drug) | — | Cash or cash equivalent | $352.00 | Research |
| Study: OLYMPUS FINAL MANUSCRIPT • Category: UROTHELIAL CANCER | ||||||
| 06/17/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $113.65 | General |
| Category: Oncology | ||||||
| 06/17/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Oncology | ||||||
| 06/14/2019 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $42.07 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 05/04/2019 | Boston Scientific Corporation | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $115.76 | General |
| Category: SCOPE | ||||||
| 05/02/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $74.62 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/02/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/16/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/16/2019 | Boston Scientific Corporation | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: SCOPE | ||||||
| 11/30/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $80.45 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OLYMPUS FINAL MANUSCRIPT | UROGEN PHARMA, INC. | $352.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 922 | 1,174 | $809,241 | $99,157 |
| 2022 | 12 | 1,020 | 1,340 | $884,336 | $100,578 |
| 2021 | 14 | 1,043 | 1,349 | $1.0M | $119,674 |
| 2020 | 14 | 1,089 | 1,369 | $1.1M | $117,714 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 400 | 525 | $148,514 | $24,631 | 16.6% |
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening | Facility | 2023 | 13 | 13 | $232,084 | $24,184 | 10.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 120 | 187 | $137,629 | $11,013 | 8.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 57 | 57 | $43,388 | $8,042 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 86 | $35,937 | $6,726 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 136 | $38,468 | $5,761 | 15.0% |
| 55840 | Removal of prostate | Facility | 2023 | 11 | 11 | $63,663 | $5,456 | 8.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $25,118 | $4,308 | 17.1% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 15 | $36,870 | $2,847 | 7.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 40 | 45 | $12,492 | $2,315 | 18.5% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 15 | 18 | $24,496 | $2,077 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $7,079 | $1,180 | 16.7% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 20 | 31 | $3,503 | $617.21 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 469 | 628 | $177,096 | $31,073 | 17.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 130 | 204 | $155,565 | $12,693 | 8.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 55 | 55 | $41,690 | $8,080 | 19.4% |
| 52354 | Biopsy and/or destruction of growth of ureter or kidney using an endoscope | Facility | 2022 | 14 | 20 | $79,222 | $7,074 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 138 | $38,916 | $6,571 | 16.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $33,352 | $6,208 | 18.6% |
| 55840 | Removal of prostate | Facility | 2022 | 12 | 12 | $83,916 | $6,083 | 7.2% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 22 | 25 | $78,350 | $5,567 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 53 | 60 | $24,960 | $4,380 | 17.5% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2022 | 11 | 13 | $57,031 | $4,234 | 7.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 16 | 26 | $55,831 | $2,669 | 4.8% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2022 | 20 | 24 | $37,128 | $1,894 | 5.1% |
About Dr. Marcus Quek, MD
Dr. Marcus Quek, MD is a Urology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457325433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Quek, MD has received a total of $6,605 in payments from pharmaceutical and medical device companies, with $249.33 received in 2024. These payments were reported across 49 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,314).
As a Medicare-enrolled provider, Quek has provided services to 4,074 Medicare beneficiaries, totaling 5,232 services with total Medicare billing of $437,123. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Maywood, IL
- Active Since 02/15/2006
- Last Updated 04/28/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1457325433
Products in Payments
- JELMYTO (Drug) $427.56
- PROVENGE (Drug) $355.78
- Erleada (Drug) $324.81
- AMS (Device) $310.84
- PROLARIS (Device) $262.60
- Androgel (Drug) $223.98
- Nubeqa (Drug) $183.81
- PERCLOT (Device) $139.52
- CYSVIEW (Drug) $136.75
- Uronav (Device) $135.88
- iTIND System (Device) $129.42
- LITHOVUE (Device) $126.54
- Cysview (Drug) $117.04
- General - Therapies (Device) $93.86
- AMS 700 (Device) $82.70
- XTANDI (Drug) $80.45
- GENERAL BPH (Device) $79.59
- SUTENT (Drug) $79.27
- COOK MEDICAL AAA (Device) $79.16
- Simplicity (Device) $78.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Maywood
Mutahar Ahmed, Md, MD
Urology — Payments: $312,946
Dr. Elizabeth Mueller
Urology — Payments: $71,585
Gopal Gupta, Md, MD
Urology — Payments: $35,040
Jeffrey Branch, Md, MD
Urology — Payments: $34,264
Michael Esposito, Md, MD
Urology — Payments: $21,408
Dr. Ahmer Farooq, D.o, D.O
Urology — Payments: $13,852